Position in NVAX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$56
-$416 QoQ
Shares Held
6
-89.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#258
of 263 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BEACON INVESTMENT ADVISORY SERVICES, INC. holds $27,845,665 across 16 Biotechnology names. NVAX ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
53,380 | $26,515,447 | |
| 2 | INCY |
Incyte Corp
|
5,608 | $635,722 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
757 | $472,019 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
14,000 | $137,480 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
99 | $29,801 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
271 | $14,780 | |
| 7 | TECH |
BIO-TECHNE Corp
|
140 | $9,891 | |
| 8 | ADMA |
Adma Biologics, Inc.
|
1,000 | $8,370 |
All Filings in NVAX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56 | 6 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $472 | 58 | Shares | Sole | 2026-04-14 | |
| No filing history on record for this holder in this stock. | ||||||